| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 258 | 2024 | 6882 | 12.890 |
Why?
|
| Psychotic Disorders | 47 | 2024 | 3046 | 3.800 |
Why?
|
| Schizophrenic Psychology | 47 | 2018 | 1678 | 3.470 |
Why?
|
| Antipsychotic Agents | 26 | 2023 | 3057 | 2.320 |
Why?
|
| Marijuana Abuse | 8 | 2022 | 403 | 2.310 |
Why?
|
| Psychiatry | 12 | 2022 | 1695 | 1.990 |
Why?
|
| Brain | 68 | 2023 | 26385 | 1.730 |
Why?
|
| Cannabis | 5 | 2023 | 439 | 1.690 |
Why?
|
| Family Health | 15 | 2014 | 1282 | 1.570 |
Why?
|
| Language | 8 | 2022 | 1471 | 1.440 |
Why?
|
| Language Disorders | 6 | 2015 | 141 | 1.380 |
Why?
|
| Genetic Linkage | 32 | 2014 | 2421 | 1.350 |
Why?
|
| Schizophrenic Language | 4 | 2019 | 69 | 1.310 |
Why?
|
| Mental Disorders | 19 | 2020 | 6600 | 1.290 |
Why?
|
| Clozapine | 3 | 2023 | 498 | 1.180 |
Why?
|
| Genetic Predisposition to Disease | 39 | 2022 | 17446 | 1.120 |
Why?
|
| Neuropsychological Tests | 27 | 2019 | 6993 | 1.030 |
Why?
|
| Language Development Disorders | 4 | 2019 | 196 | 0.990 |
Why?
|
| Cerebral Ventricles | 18 | 2010 | 544 | 0.960 |
Why?
|
| Publishing | 2 | 2022 | 833 | 0.880 |
Why?
|
| X Chromosome | 13 | 2000 | 814 | 0.880 |
Why?
|
| Bombs | 1 | 2022 | 72 | 0.830 |
Why?
|
| Humans | 321 | 2024 | 744343 | 0.800 |
Why?
|
| Psychoses, Substance-Induced | 3 | 2017 | 96 | 0.770 |
Why?
|
| Genetics, Behavioral | 3 | 2011 | 53 | 0.740 |
Why?
|
| Cerebral Cortex | 14 | 2015 | 5708 | 0.710 |
Why?
|
| Peer Review | 1 | 2022 | 209 | 0.700 |
Why?
|
| Brain Mapping | 13 | 2019 | 6669 | 0.670 |
Why?
|
| Cognition Disorders | 14 | 2017 | 4043 | 0.660 |
Why?
|
| Agranulocytosis | 1 | 2018 | 101 | 0.660 |
Why?
|
| Cannabinoids | 1 | 2021 | 166 | 0.650 |
Why?
|
| Research Personnel | 2 | 2022 | 573 | 0.650 |
Why?
|
| Magnetic Resonance Imaging | 49 | 2019 | 35421 | 0.650 |
Why?
|
| Klinefelter Syndrome | 4 | 2009 | 48 | 0.650 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2021 | 4266 | 0.640 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2019 | 168 | 0.640 |
Why?
|
| Schizophrenia, Paranoid | 4 | 2018 | 104 | 0.630 |
Why?
|
| Hallucinogens | 1 | 2021 | 180 | 0.620 |
Why?
|
| Veterans Health | 1 | 2019 | 216 | 0.600 |
Why?
|
| Psychiatric Status Rating Scales | 29 | 2016 | 6038 | 0.580 |
Why?
|
| Hospitals, Veterans | 1 | 2019 | 404 | 0.570 |
Why?
|
| Speech Perception | 3 | 2016 | 489 | 0.560 |
Why?
|
| Speech Disorders | 2 | 2012 | 189 | 0.560 |
Why?
|
| Research | 6 | 2014 | 1999 | 0.560 |
Why?
|
| Family | 20 | 2016 | 3147 | 0.560 |
Why?
|
| Pharmacogenetics | 3 | 2018 | 675 | 0.560 |
Why?
|
| Dominance, Cerebral | 12 | 2019 | 635 | 0.550 |
Why?
|
| Leadership | 2 | 2022 | 1357 | 0.540 |
Why?
|
| Genetic Markers | 24 | 2016 | 2634 | 0.540 |
Why?
|
| Functional Laterality | 19 | 2016 | 2290 | 0.540 |
Why?
|
| Congresses as Topic | 2 | 2012 | 764 | 0.540 |
Why?
|
| Peer Review, Research | 1 | 2019 | 329 | 0.530 |
Why?
|
| Veterans | 5 | 2022 | 2519 | 0.530 |
Why?
|
| Sex Chromosome Aberrations | 8 | 2000 | 114 | 0.530 |
Why?
|
| Male | 171 | 2022 | 350118 | 0.510 |
Why?
|
| Semantics | 5 | 2013 | 584 | 0.500 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 2065 | 0.500 |
Why?
|
| Suicide | 4 | 2021 | 1477 | 0.490 |
Why?
|
| Mental Health | 3 | 2024 | 3019 | 0.480 |
Why?
|
| Cognition | 11 | 2021 | 6770 | 0.480 |
Why?
|
| Chromosome Mapping | 26 | 2014 | 4740 | 0.470 |
Why?
|
| Adult | 128 | 2022 | 214055 | 0.470 |
Why?
|
| Refugees | 1 | 2021 | 511 | 0.470 |
Why?
|
| Nerve Tissue Proteins | 10 | 2016 | 4462 | 0.470 |
Why?
|
| Female | 169 | 2023 | 380194 | 0.460 |
Why?
|
| Faculty, Medical | 1 | 2021 | 1181 | 0.450 |
Why?
|
| Neural Pathways | 6 | 2016 | 2972 | 0.440 |
Why?
|
| Temporal Lobe | 13 | 2005 | 1670 | 0.440 |
Why?
|
| Analysis of Variance | 14 | 2013 | 6365 | 0.440 |
Why?
|
| Genome-Wide Association Study | 17 | 2022 | 12261 | 0.440 |
Why?
|
| Marketing of Health Services | 1 | 2014 | 153 | 0.440 |
Why?
|
| Genome, Human | 11 | 2013 | 4420 | 0.440 |
Why?
|
| Psychotherapy | 3 | 2024 | 1643 | 0.430 |
Why?
|
| Association | 1 | 2012 | 53 | 0.420 |
Why?
|
| Genetic Testing | 7 | 2014 | 3444 | 0.420 |
Why?
|
| Chromosomes, Human, X | 4 | 2007 | 296 | 0.420 |
Why?
|
| Chromosomes, Human | 4 | 2008 | 457 | 0.420 |
Why?
|
| Journalism, Medical | 1 | 2012 | 74 | 0.420 |
Why?
|
| Pedigree | 29 | 2021 | 4644 | 0.420 |
Why?
|
| Memory, Short-Term | 2 | 2016 | 975 | 0.400 |
Why?
|
| Biomedical Research | 3 | 2012 | 3309 | 0.390 |
Why?
|
| Genes, X-Linked | 2 | 2010 | 128 | 0.380 |
Why?
|
| Bipolar Disorder | 19 | 2023 | 5027 | 0.380 |
Why?
|
| Nerve Net | 3 | 2019 | 2174 | 0.370 |
Why?
|
| Verbal Learning | 5 | 2013 | 467 | 0.370 |
Why?
|
| Endophenotypes | 4 | 2017 | 250 | 0.370 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 6 | 2012 | 1953 | 0.370 |
Why?
|
| Molecular Biology | 4 | 2010 | 596 | 0.360 |
Why?
|
| Hospitalization | 8 | 2019 | 10262 | 0.360 |
Why?
|
| Schizotypal Personality Disorder | 3 | 2009 | 288 | 0.360 |
Why?
|
| Hallucinations | 4 | 2022 | 360 | 0.350 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2018 | 1541 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2009 | 245 | 0.350 |
Why?
|
| Ethics, Medical | 1 | 2014 | 792 | 0.330 |
Why?
|
| Mental Health Services | 1 | 2020 | 1643 | 0.330 |
Why?
|
| Depressive Disorder, Major | 3 | 2022 | 4644 | 0.330 |
Why?
|
| Technology | 1 | 2011 | 305 | 0.320 |
Why?
|
| Research Support as Topic | 1 | 2013 | 705 | 0.320 |
Why?
|
| Quality of Life | 3 | 2023 | 12804 | 0.320 |
Why?
|
| Science | 1 | 2011 | 241 | 0.320 |
Why?
|
| Neuronal Plasticity | 4 | 2022 | 1422 | 0.320 |
Why?
|
| Monoamine Oxidase | 9 | 2010 | 178 | 0.320 |
Why?
|
| International Cooperation | 1 | 2014 | 1420 | 0.310 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2009 | 2737 | 0.300 |
Why?
|
| Psychopharmacology | 1 | 2009 | 143 | 0.300 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 957 | 0.300 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2018 | 8949 | 0.290 |
Why?
|
| Aging | 3 | 2021 | 8664 | 0.290 |
Why?
|
| Evoked Potentials | 1 | 2013 | 1056 | 0.290 |
Why?
|
| Young Adult | 22 | 2019 | 56430 | 0.290 |
Why?
|
| Drug Therapy | 1 | 2010 | 497 | 0.290 |
Why?
|
| Adolescent | 40 | 2021 | 85781 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 2 | 5 | 2007 | 326 | 0.280 |
Why?
|
| Polymorphism, Genetic | 16 | 2011 | 4328 | 0.280 |
Why?
|
| Perphenazine | 1 | 2005 | 34 | 0.280 |
Why?
|
| Risk Factors | 26 | 2024 | 72290 | 0.280 |
Why?
|
| Risperidone | 2 | 2005 | 383 | 0.280 |
Why?
|
| Brain Diseases | 6 | 2018 | 1563 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2007 | 460 | 0.270 |
Why?
|
| Italy | 3 | 2014 | 832 | 0.270 |
Why?
|
| Genetic Privacy | 1 | 2006 | 60 | 0.260 |
Why?
|
| Dibenzothiazepines | 1 | 2005 | 103 | 0.260 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2013 | 2305 | 0.260 |
Why?
|
| Risk | 8 | 2019 | 9687 | 0.250 |
Why?
|
| Microsatellite Repeats | 5 | 2010 | 802 | 0.250 |
Why?
|
| Occipital Lobe | 7 | 2019 | 379 | 0.250 |
Why?
|
| Y Chromosome | 4 | 1994 | 206 | 0.240 |
Why?
|
| Lod Score | 9 | 2010 | 614 | 0.240 |
Why?
|
| Depressive Disorder | 12 | 2018 | 3748 | 0.240 |
Why?
|
| Genetic Heterogeneity | 2 | 2007 | 733 | 0.240 |
Why?
|
| Inheritance Patterns | 4 | 2014 | 340 | 0.240 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2004 | 113 | 0.240 |
Why?
|
| Tomography, Emission-Computed | 11 | 1989 | 1144 | 0.230 |
Why?
|
| Prefrontal Cortex | 4 | 2019 | 2147 | 0.230 |
Why?
|
| Autoantigens | 1 | 2007 | 892 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2022 | 15519 | 0.220 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2001 | 202 | 0.220 |
Why?
|
| Genetics | 2 | 2018 | 112 | 0.220 |
Why?
|
| Genetics, Medical | 3 | 2006 | 338 | 0.220 |
Why?
|
| Genotype | 20 | 2017 | 12951 | 0.220 |
Why?
|
| Sequence Analysis, DNA | 8 | 2014 | 4803 | 0.210 |
Why?
|
| Ukraine | 1 | 2022 | 111 | 0.210 |
Why?
|
| Age of Onset | 7 | 2012 | 3271 | 0.210 |
Why?
|
| Psychology | 1 | 2004 | 356 | 0.210 |
Why?
|
| Alleles | 16 | 2022 | 6933 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5319 | 0.200 |
Why?
|
| Transcription Factors | 4 | 2016 | 12208 | 0.200 |
Why?
|
| Mutation | 12 | 2022 | 29786 | 0.200 |
Why?
|
| Middle Aged | 47 | 2022 | 213383 | 0.200 |
Why?
|
| Sex Factors | 15 | 2016 | 10397 | 0.200 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2011 | 615 | 0.200 |
Why?
|
| Comorbidity | 4 | 2020 | 10388 | 0.200 |
Why?
|
| Language Tests | 2 | 2013 | 200 | 0.200 |
Why?
|
| History, 20th Century | 5 | 2012 | 2740 | 0.200 |
Why?
|
| Linkage Disequilibrium | 4 | 2004 | 1997 | 0.190 |
Why?
|
| Psychotropic Drugs | 2 | 2018 | 894 | 0.190 |
Why?
|
| Minors | 1 | 2021 | 50 | 0.190 |
Why?
|
| International Agencies | 2 | 2012 | 240 | 0.190 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7659 | 0.190 |
Why?
|
| Interview, Psychological | 2 | 2015 | 812 | 0.190 |
Why?
|
| Sex Characteristics | 4 | 2016 | 2585 | 0.190 |
Why?
|
| Anticipation, Genetic | 1 | 1999 | 5 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2000 | 197 | 0.180 |
Why?
|
| Inflammation | 1 | 2020 | 10638 | 0.180 |
Why?
|
| Terrorism | 1 | 2003 | 211 | 0.180 |
Why?
|
| Behavior | 2 | 2016 | 561 | 0.180 |
Why?
|
| Achievement | 1 | 2021 | 291 | 0.180 |
Why?
|
| Reference Values | 5 | 2012 | 4982 | 0.180 |
Why?
|
| Disease Progression | 9 | 2010 | 13284 | 0.180 |
Why?
|
| Lithium | 2 | 2022 | 601 | 0.180 |
Why?
|
| Models, Genetic | 5 | 2010 | 3494 | 0.180 |
Why?
|
| Costa Rica | 5 | 2013 | 177 | 0.180 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2020 | 295 | 0.170 |
Why?
|
| Attitude | 1 | 2004 | 776 | 0.170 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9648 | 0.170 |
Why?
|
| Oxygen | 5 | 2014 | 4189 | 0.170 |
Why?
|
| Psychological Techniques | 1 | 2019 | 45 | 0.170 |
Why?
|
| Gene Dosage | 5 | 2011 | 1252 | 0.170 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2018 | 21 | 0.170 |
Why?
|
| Nicotine | 1 | 2024 | 681 | 0.170 |
Why?
|
| Memory | 6 | 2013 | 2174 | 0.170 |
Why?
|
| Centromere | 1 | 1999 | 220 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 7181 | 0.160 |
Why?
|
| Translocation, Genetic | 3 | 2009 | 1420 | 0.160 |
Why?
|
| Mesencephalon | 1 | 2000 | 329 | 0.160 |
Why?
|
| Sex Chromosomes | 2 | 2009 | 105 | 0.160 |
Why?
|
| Karyotyping | 6 | 2009 | 1243 | 0.160 |
Why?
|
| Chromosomes, Human, Y | 3 | 2004 | 148 | 0.160 |
Why?
|
| History, 21st Century | 3 | 2012 | 1534 | 0.160 |
Why?
|
| Altitude | 1 | 2019 | 161 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2010 | 354 | 0.160 |
Why?
|
| DNA Copy Number Variations | 3 | 2021 | 1941 | 0.160 |
Why?
|
| Chronic Disease | 25 | 2003 | 9146 | 0.160 |
Why?
|
| Hippocampus | 6 | 2013 | 3675 | 0.160 |
Why?
|
| Siblings | 5 | 2016 | 854 | 0.160 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2009 | 178 | 0.150 |
Why?
|
| Statistics as Topic | 3 | 2014 | 2373 | 0.150 |
Why?
|
| Receptor, trkB | 1 | 2018 | 125 | 0.150 |
Why?
|
| Intelligence | 3 | 2017 | 920 | 0.150 |
Why?
|
| Birth Order | 2 | 2016 | 95 | 0.150 |
Why?
|
| Prevalence | 6 | 2023 | 15226 | 0.150 |
Why?
|
| Societies, Medical | 4 | 2018 | 3743 | 0.150 |
Why?
|
| Anisotropy | 2 | 2013 | 1265 | 0.150 |
Why?
|
| Follow-Up Studies | 16 | 2019 | 39050 | 0.150 |
Why?
|
| Aptitude | 1 | 2017 | 45 | 0.150 |
Why?
|
| Expressed Emotion | 1 | 2018 | 92 | 0.150 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2018 | 195 | 0.150 |
Why?
|
| Case-Control Studies | 12 | 2022 | 21746 | 0.150 |
Why?
|
| Motivation | 2 | 2018 | 1971 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 1432 | 0.140 |
Why?
|
| Genetic Variation | 5 | 2018 | 6544 | 0.140 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 302 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2009 | 403 | 0.140 |
Why?
|
| Antidepressive Agents | 2 | 2020 | 2838 | 0.140 |
Why?
|
| Head | 1 | 2022 | 880 | 0.140 |
Why?
|
| Mentors | 1 | 2021 | 631 | 0.140 |
Why?
|
| Dopamine beta-Hydroxylase | 5 | 1984 | 75 | 0.140 |
Why?
|
| Developing Countries | 1 | 2009 | 2815 | 0.140 |
Why?
|
| Disasters | 1 | 2002 | 511 | 0.140 |
Why?
|
| Cohort Studies | 17 | 2016 | 40561 | 0.140 |
Why?
|
| Boston | 3 | 2019 | 9313 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3462 | 0.130 |
Why?
|
| Lymphocytes | 6 | 2009 | 2617 | 0.130 |
Why?
|
| Phenotype | 11 | 2018 | 16365 | 0.130 |
Why?
|
| Autistic Disorder | 2 | 2023 | 1185 | 0.130 |
Why?
|
| Frontal Lobe | 6 | 2010 | 1406 | 0.130 |
Why?
|
| Nuclear Family | 3 | 2002 | 318 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1996 | 380 | 0.130 |
Why?
|
| Genetic Research | 2 | 2007 | 174 | 0.130 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 798 | 0.130 |
Why?
|
| Minority Groups | 1 | 2023 | 1223 | 0.130 |
Why?
|
| Frameshift Mutation | 2 | 2009 | 399 | 0.130 |
Why?
|
| Depression | 3 | 2023 | 7766 | 0.130 |
Why?
|
| Corpus Callosum | 3 | 1997 | 737 | 0.130 |
Why?
|
| Atrophy | 7 | 2006 | 1583 | 0.130 |
Why?
|
| Hypothyroidism | 1 | 2000 | 658 | 0.130 |
Why?
|
| Herpesviridae Infections | 2 | 1987 | 277 | 0.130 |
Why?
|
| Pituitary-Adrenal System | 1 | 2018 | 553 | 0.130 |
Why?
|
| Mood Disorders | 5 | 1998 | 1106 | 0.130 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 3508 | 0.120 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 703 | 0.120 |
Why?
|
| Severity of Illness Index | 10 | 2018 | 15540 | 0.120 |
Why?
|
| Medical History Taking | 1 | 2018 | 783 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 2009 | 230 | 0.120 |
Why?
|
| Chromosome Aberrations | 5 | 1994 | 1813 | 0.120 |
Why?
|
| Early Diagnosis | 3 | 2010 | 1184 | 0.120 |
Why?
|
| Gene Frequency | 9 | 2014 | 3588 | 0.120 |
Why?
|
| Septum Pellucidum | 1 | 1993 | 58 | 0.120 |
Why?
|
| Child | 16 | 2022 | 77709 | 0.120 |
Why?
|
| Allelic Imbalance | 1 | 2013 | 77 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 3158 | 0.110 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 1221 | 0.110 |
Why?
|
| Reaction Time | 2 | 2013 | 2097 | 0.110 |
Why?
|
| Cannabidiol | 1 | 2015 | 106 | 0.110 |
Why?
|
| Recurrence | 2 | 2023 | 8340 | 0.110 |
Why?
|
| Genetic Loci | 3 | 2019 | 2575 | 0.110 |
Why?
|
| Drug Discovery | 2 | 2013 | 1058 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1850 | 0.110 |
Why?
|
| Maternal Age | 1 | 2016 | 802 | 0.110 |
Why?
|
| Bioethical Issues | 1 | 2014 | 124 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 2 | 2010 | 1344 | 0.110 |
Why?
|
| Word Association Tests | 1 | 2012 | 57 | 0.110 |
Why?
|
| Theory of Mind | 1 | 2014 | 86 | 0.110 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 895 | 0.100 |
Why?
|
| Editorial Policies | 1 | 2016 | 451 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2006 | 658 | 0.100 |
Why?
|
| Immunoglobulins | 3 | 1986 | 881 | 0.100 |
Why?
|
| New York City | 2 | 2004 | 710 | 0.100 |
Why?
|
| Vocabulary | 2 | 2015 | 169 | 0.100 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2011 | 6 | 0.100 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 3647 | 0.100 |
Why?
|
| Aneuploidy | 3 | 2009 | 530 | 0.100 |
Why?
|
| Genes, Duplicate | 1 | 2011 | 33 | 0.100 |
Why?
|
| Trinucleotide Repeats | 3 | 1996 | 261 | 0.100 |
Why?
|
| Patient Admission | 1 | 1998 | 1380 | 0.100 |
Why?
|
| Quadruplets | 3 | 1984 | 9 | 0.100 |
Why?
|
| Brain Damage, Chronic | 2 | 1991 | 265 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 504 | 0.090 |
Why?
|
| Mental Recall | 1 | 1997 | 1205 | 0.090 |
Why?
|
| Consensus | 2 | 2017 | 2959 | 0.090 |
Why?
|
| Menarche | 1 | 1993 | 516 | 0.090 |
Why?
|
| Greece | 1 | 2011 | 344 | 0.090 |
Why?
|
| Cadherins | 2 | 2006 | 907 | 0.090 |
Why?
|
| Germany | 1 | 2013 | 862 | 0.090 |
Why?
|
| Spain | 2 | 2002 | 465 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2011 | 142 | 0.090 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2004 | 243 | 0.090 |
Why?
|
| Myocarditis | 1 | 2018 | 771 | 0.090 |
Why?
|
| Organ Size | 1 | 2015 | 2252 | 0.090 |
Why?
|
| MEDLINE | 1 | 2010 | 125 | 0.090 |
Why?
|
| Puberty | 1 | 1993 | 490 | 0.090 |
Why?
|
| Nephritis, Hereditary | 1 | 1990 | 88 | 0.090 |
Why?
|
| Retrospective Studies | 6 | 2023 | 77449 | 0.090 |
Why?
|
| Glucose | 8 | 2009 | 4397 | 0.090 |
Why?
|
| Affect | 1 | 2018 | 1476 | 0.090 |
Why?
|
| Terminology as Topic | 2 | 2012 | 1547 | 0.090 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 728 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2021 | 63114 | 0.090 |
Why?
|
| Genomics | 3 | 2022 | 5720 | 0.090 |
Why?
|
| Longitudinal Studies | 5 | 2010 | 13989 | 0.090 |
Why?
|
| Societies, Scientific | 1 | 2010 | 220 | 0.090 |
Why?
|
| Genomic Imprinting | 2 | 2002 | 328 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 265 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 1151 | 0.090 |
Why?
|
| Base Sequence | 11 | 2014 | 12797 | 0.090 |
Why?
|
| Statistics, Nonparametric | 3 | 2017 | 2886 | 0.090 |
Why?
|
| R-SNARE Proteins | 2 | 2006 | 74 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2020 | 2708 | 0.080 |
Why?
|
| Military Personnel | 1 | 2018 | 1133 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 9 | 2009 | 6171 | 0.080 |
Why?
|
| United States | 10 | 2020 | 69872 | 0.080 |
Why?
|
| Virus Diseases | 2 | 1986 | 711 | 0.080 |
Why?
|
| Psychometrics | 2 | 2010 | 3002 | 0.080 |
Why?
|
| Personality Disorders | 1 | 1993 | 713 | 0.080 |
Why?
|
| Catatonia | 1 | 1991 | 158 | 0.080 |
Why?
|
| Internship and Residency | 2 | 2019 | 5788 | 0.080 |
Why?
|
| Cerebral Ventriculography | 3 | 1985 | 44 | 0.080 |
Why?
|
| Executive Function | 1 | 2017 | 1364 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2002 | 351 | 0.080 |
Why?
|
| Inpatients | 1 | 2020 | 2518 | 0.080 |
Why?
|
| Gene Duplication | 1 | 2009 | 329 | 0.080 |
Why?
|
| Exons | 5 | 2009 | 2437 | 0.080 |
Why?
|
| Forecasting | 2 | 2009 | 2951 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 5867 | 0.080 |
Why?
|
| Economics | 1 | 2009 | 146 | 0.080 |
Why?
|
| Tandem Repeat Sequences | 1 | 2009 | 185 | 0.080 |
Why?
|
| Memory Disorders | 2 | 2013 | 1184 | 0.080 |
Why?
|
| Disease Susceptibility | 3 | 2008 | 1782 | 0.080 |
Why?
|
| Membrane Proteins | 5 | 2014 | 7880 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2899 | 0.080 |
Why?
|
| Thyroid Diseases | 1 | 1991 | 379 | 0.080 |
Why?
|
| Aged | 10 | 2021 | 163280 | 0.080 |
Why?
|
| Phenethylamines | 2 | 1984 | 96 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1257 | 0.080 |
Why?
|
| DNA Methylation | 3 | 2014 | 4286 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 281 | 0.080 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 1984 | 93 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 3768 | 0.070 |
Why?
|
| Diseases in Twins | 4 | 2000 | 449 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 3 | 1987 | 1041 | 0.070 |
Why?
|
| Social Behavior | 1 | 2014 | 1127 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2005 | 4933 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.070 |
Why?
|
| Animals | 17 | 2016 | 168757 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 2018 | 2690 | 0.070 |
Why?
|
| Semaphorin-3A | 1 | 2006 | 39 | 0.070 |
Why?
|
| DNA Mutational Analysis | 7 | 2013 | 4186 | 0.070 |
Why?
|
| Pregnancy | 9 | 2023 | 29144 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 57776 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2016 | 2057 | 0.070 |
Why?
|
| Parahippocampal Gyrus | 1 | 2006 | 116 | 0.070 |
Why?
|
| MicroRNAs | 2 | 2014 | 3752 | 0.070 |
Why?
|
| Acyclovir | 1 | 1987 | 272 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 2007 | 339 | 0.070 |
Why?
|
| Photic Stimulation | 1 | 2012 | 2025 | 0.070 |
Why?
|
| Dyskinesia, Drug-Induced | 3 | 1983 | 163 | 0.070 |
Why?
|
| Cell Line | 3 | 2016 | 15997 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 1708 | 0.070 |
Why?
|
| GTPase-Activating Proteins | 1 | 2009 | 498 | 0.070 |
Why?
|
| Obstetric Labor Complications | 1 | 1988 | 238 | 0.070 |
Why?
|
| Reading | 2 | 2007 | 558 | 0.060 |
Why?
|
| Cross-Cultural Comparison | 1 | 2009 | 651 | 0.060 |
Why?
|
| Molecular Sequence Data | 8 | 2014 | 18111 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3920 | 0.060 |
Why?
|
| Japan | 1 | 2009 | 1360 | 0.060 |
Why?
|
| Limbic System | 1 | 1988 | 426 | 0.060 |
Why?
|
| Haloperidol | 2 | 2004 | 397 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 2010 | 1401 | 0.060 |
Why?
|
| Antibodies, Viral | 4 | 1996 | 3176 | 0.060 |
Why?
|
| Telomere | 2 | 2008 | 910 | 0.060 |
Why?
|
| Retroviridae Infections | 1 | 1985 | 151 | 0.060 |
Why?
|
| Developmental Disabilities | 2 | 2010 | 1456 | 0.060 |
Why?
|
| Geriatrics | 1 | 2009 | 396 | 0.060 |
Why?
|
| Reproducibility of Results | 5 | 2011 | 19905 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2008 | 20129 | 0.060 |
Why?
|
| Prejudice | 1 | 2009 | 570 | 0.060 |
Why?
|
| Color Perception | 1 | 2005 | 213 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 2418 | 0.060 |
Why?
|
| Chromosome Banding | 2 | 1996 | 278 | 0.060 |
Why?
|
| Serotonin | 4 | 1986 | 1017 | 0.060 |
Why?
|
| Myelin Proteins | 1 | 2005 | 215 | 0.060 |
Why?
|
| Drug Tolerance | 1 | 2005 | 376 | 0.060 |
Why?
|
| Glycols | 1 | 1983 | 59 | 0.060 |
Why?
|
| Blood Platelets | 5 | 1983 | 2508 | 0.060 |
Why?
|
| Cell Line, Transformed | 3 | 2010 | 898 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3597 | 0.060 |
Why?
|
| Telomerase | 1 | 2008 | 730 | 0.060 |
Why?
|
| Immune System Diseases | 1 | 1986 | 262 | 0.060 |
Why?
|
| Parents | 2 | 1996 | 3407 | 0.060 |
Why?
|
| Capsid Proteins | 1 | 1986 | 479 | 0.060 |
Why?
|
| Herpes Simplex | 1 | 1986 | 470 | 0.060 |
Why?
|
| Linear Models | 1 | 2013 | 5952 | 0.060 |
Why?
|
| Alcoholism | 2 | 2012 | 1906 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 12072 | 0.060 |
Why?
|
| Chromosome Disorders | 4 | 1994 | 514 | 0.060 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 950 | 0.050 |
Why?
|
| Anxiety | 2 | 2009 | 4297 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 513 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 18029 | 0.050 |
Why?
|
| Fenclonine | 1 | 1982 | 16 | 0.050 |
Why?
|
| Psychomotor Agitation | 1 | 2004 | 293 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2010 | 2564 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12959 | 0.050 |
Why?
|
| Parietal Lobe | 4 | 2019 | 838 | 0.050 |
Why?
|
| Age Factors | 7 | 2008 | 18370 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 9438 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2010 | 6459 | 0.050 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1988 | 582 | 0.050 |
Why?
|
| Caudate Nucleus | 3 | 1997 | 393 | 0.050 |
Why?
|
| HLA Antigens | 3 | 2020 | 1381 | 0.050 |
Why?
|
| Neuropeptides | 2 | 2004 | 942 | 0.050 |
Why?
|
| Deoxyglucose | 6 | 1989 | 337 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2002 | 299 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 1504 | 0.050 |
Why?
|
| Sex Distribution | 2 | 1998 | 2297 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2002 | 256 | 0.050 |
Why?
|
| Receptors, Glycine | 1 | 2001 | 32 | 0.050 |
Why?
|
| Ethics | 1 | 2001 | 94 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2001 | 64 | 0.050 |
Why?
|
| Stem Cells | 1 | 2014 | 3567 | 0.050 |
Why?
|
| Gene Expression | 3 | 2009 | 7799 | 0.050 |
Why?
|
| Research Design | 4 | 2007 | 5987 | 0.050 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 4258 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 2009 | 1411 | 0.050 |
Why?
|
| Mice | 7 | 2013 | 81183 | 0.050 |
Why?
|
| Synapses | 1 | 2010 | 1728 | 0.050 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 31 | 0.050 |
Why?
|
| Chromosome Fragility | 2 | 1991 | 16 | 0.050 |
Why?
|
| Dilatation, Pathologic | 2 | 1992 | 520 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2020 | 106 | 0.050 |
Why?
|
| Chromosome Fragile Sites | 2 | 1991 | 27 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 2 | 1999 | 1061 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1984 | 547 | 0.040 |
Why?
|
| Circadian Rhythm | 2 | 2009 | 2624 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 1 | 1986 | 820 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.040 |
Why?
|
| Phosphorus Isotopes | 1 | 2019 | 126 | 0.040 |
Why?
|
| DNA | 6 | 2006 | 7301 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2005 | 1101 | 0.040 |
Why?
|
| Motor Skills | 1 | 2003 | 522 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 2011 | 13815 | 0.040 |
Why?
|
| Blood Glucose | 3 | 1989 | 6256 | 0.040 |
Why?
|
| Pattern Recognition, Visual | 1 | 2005 | 824 | 0.040 |
Why?
|
| Utah | 1 | 2019 | 126 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 1405 | 0.040 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2018 | 544 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2004 | 375 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2010 | 2684 | 0.040 |
Why?
|
| Retroviridae | 2 | 1996 | 914 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 1999 | 288 | 0.040 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2009 | 126 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2011 | 2751 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1983 | 1369 | 0.040 |
Why?
|
| DNA Primers | 4 | 2010 | 2892 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1285 | 0.040 |
Why?
|
| Privacy | 1 | 2001 | 239 | 0.040 |
Why?
|
| Phosphocreatine | 1 | 2019 | 269 | 0.040 |
Why?
|
| Visual Perception | 1 | 2007 | 1420 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1991 | 768 | 0.040 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 2866 | 0.040 |
Why?
|
| Antimanic Agents | 1 | 2022 | 522 | 0.040 |
Why?
|
| Life Change Events | 1 | 2003 | 938 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2016 | 53288 | 0.040 |
Why?
|
| Killer Cells, Natural | 2 | 1986 | 2133 | 0.040 |
Why?
|
| Homozygote | 1 | 2002 | 1785 | 0.040 |
Why?
|
| Hand | 1 | 2003 | 884 | 0.040 |
Why?
|
| Diarrhea Viruses, Bovine Viral | 1 | 1996 | 6 | 0.040 |
Why?
|
| Dichotic Listening Tests | 1 | 1996 | 22 | 0.040 |
Why?
|
| Germ Cells | 1 | 2021 | 631 | 0.040 |
Why?
|
| Speech Production Measurement | 1 | 1997 | 98 | 0.040 |
Why?
|
| Neurons | 3 | 2013 | 9338 | 0.040 |
Why?
|
| Cephalometry | 1 | 1998 | 382 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 1996 | 67 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2000 | 1005 | 0.040 |
Why?
|
| Syndrome | 2 | 2000 | 3251 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2010 | 5021 | 0.040 |
Why?
|
| Health Policy | 1 | 2009 | 2661 | 0.030 |
Why?
|
| Data Collection | 2 | 2003 | 3341 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4751 | 0.030 |
Why?
|
| Autoantibodies | 1 | 1985 | 2035 | 0.030 |
Why?
|
| Genes | 1 | 2000 | 1893 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2009 | 2348 | 0.030 |
Why?
|
| Huntington Disease | 3 | 1996 | 1124 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2009 | 3658 | 0.030 |
Why?
|
| Decision Making | 1 | 2010 | 3887 | 0.030 |
Why?
|
| Phosphates | 1 | 2019 | 786 | 0.030 |
Why?
|
| Helminth Proteins | 1 | 1996 | 171 | 0.030 |
Why?
|
| Basal Ganglia | 3 | 1987 | 546 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14722 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2001 | 1076 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2440 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 2557 | 0.030 |
Why?
|
| Sleep | 2 | 2009 | 4623 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2004 | 1572 | 0.030 |
Why?
|
| Cyclic AMP | 2 | 2011 | 1472 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1994 | 69 | 0.030 |
Why?
|
| Legislation, Drug | 1 | 2016 | 206 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2018 | 811 | 0.030 |
Why?
|
| Denmark | 1 | 2016 | 738 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2013 | 126 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1988 | 2861 | 0.030 |
Why?
|
| Rural Health | 1 | 1975 | 305 | 0.030 |
Why?
|
| Transfection | 2 | 2013 | 5892 | 0.030 |
Why?
|
| Thymine | 1 | 1993 | 68 | 0.030 |
Why?
|
| Attention | 3 | 1997 | 2400 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2023 | 25625 | 0.030 |
Why?
|
| Isoleucine | 1 | 2013 | 112 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 1091 | 0.030 |
Why?
|
| Receptors, Dopamine | 1 | 1994 | 295 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2001 | 2187 | 0.030 |
Why?
|
| Immunoglobulin G | 4 | 1986 | 4560 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 2025 | 0.030 |
Why?
|
| Time Factors | 3 | 2004 | 40075 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 1975 | 155 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2022 | 1248 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1994 | 291 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 2576 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2014 | 365 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2022 | 12026 | 0.030 |
Why?
|
| Prognosis | 5 | 2014 | 29063 | 0.030 |
Why?
|
| Cytosine | 1 | 1993 | 216 | 0.030 |
Why?
|
| Acute Disease | 1 | 2002 | 7149 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5137 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 2 | 2000 | 2731 | 0.030 |
Why?
|
| Judgment | 1 | 2014 | 281 | 0.020 |
Why?
|
| Codon | 1 | 1993 | 611 | 0.020 |
Why?
|
| Environment | 3 | 1987 | 1124 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 413 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 2839 | 0.020 |
Why?
|
| Seasons | 2 | 1987 | 1493 | 0.020 |
Why?
|
| Personality Development | 1 | 1991 | 245 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2020 | 1916 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2011 | 126 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2014 | 1547 | 0.020 |
Why?
|
| Social Control, Formal | 2 | 1985 | 110 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2010 | 57 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2005 | 7913 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 322 | 0.020 |
Why?
|
| Cerebellum | 1 | 1997 | 1488 | 0.020 |
Why?
|
| Software | 2 | 2010 | 4443 | 0.020 |
Why?
|
| Culture | 1 | 2014 | 633 | 0.020 |
Why?
|
| Immunoglobulin A | 2 | 1984 | 992 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1996 | 1904 | 0.020 |
Why?
|
| Probability | 1 | 2015 | 2505 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1996 | 852 | 0.020 |
Why?
|
| COS Cells | 1 | 2011 | 1161 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 3760 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2010 | 175 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2009 | 255 | 0.020 |
Why?
|
| Algorithms | 2 | 2010 | 13881 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 1989 | 149 | 0.020 |
Why?
|
| Zebrafish | 2 | 2010 | 2994 | 0.020 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2009 | 101 | 0.020 |
Why?
|
| Larva | 1 | 2010 | 519 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2010 | 496 | 0.020 |
Why?
|
| Immunoglobulin M | 2 | 1984 | 1537 | 0.020 |
Why?
|
| Multigene Family | 1 | 2011 | 1102 | 0.020 |
Why?
|
| Fluorine | 2 | 1985 | 83 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.020 |
Why?
|
| Haplotypes | 1 | 2014 | 2779 | 0.020 |
Why?
|
| Macrophages | 1 | 1983 | 5655 | 0.020 |
Why?
|
| Age Distribution | 1 | 1994 | 2902 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2009 | 235 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2003 | 4245 | 0.020 |
Why?
|
| Turner Syndrome | 1 | 2009 | 130 | 0.020 |
Why?
|
| Social Class | 1 | 1996 | 1999 | 0.020 |
Why?
|
| Child of Impaired Parents | 1 | 1991 | 455 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1993 | 1121 | 0.020 |
Why?
|
| Physicians | 1 | 2006 | 4567 | 0.020 |
Why?
|
| Computational Biology | 2 | 2010 | 3521 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 2088 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 4 | 1989 | 2016 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1114 | 0.020 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1986 | 90 | 0.020 |
Why?
|
| Callitrichinae | 1 | 1986 | 23 | 0.020 |
Why?
|
| Patient Selection | 1 | 1999 | 4215 | 0.020 |
Why?
|
| Encephalitis, Arbovirus | 1 | 1986 | 3 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1996 | 2421 | 0.020 |
Why?
|
| Radioisotopes | 2 | 1985 | 499 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 547 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 1425 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2010 | 41006 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 1081 | 0.020 |
Why?
|
| Social Environment | 1 | 1991 | 1023 | 0.020 |
Why?
|
| Affective Disorders, Psychotic | 1 | 1987 | 191 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2013 | 19229 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2007 | 23338 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 4320 | 0.020 |
Why?
|
| Clone Cells | 1 | 2009 | 1692 | 0.020 |
Why?
|
| Scotland | 1 | 2005 | 155 | 0.020 |
Why?
|
| Survival Rate | 1 | 1999 | 12788 | 0.020 |
Why?
|
| Influenza, Human | 1 | 1996 | 1479 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 1989 | 647 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 1549 | 0.020 |
Why?
|
| Dangerous Behavior | 1 | 1985 | 66 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1984 | 64 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2703 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1984 | 75 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1989 | 712 | 0.020 |
Why?
|
| Phenylacetates | 1 | 1984 | 114 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1985 | 248 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1984 | 149 | 0.020 |
Why?
|
| Phenylalanine | 2 | 1983 | 365 | 0.020 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1986 | 243 | 0.020 |
Why?
|
| Heterozygote | 2 | 2009 | 2804 | 0.020 |
Why?
|
| Delusions | 2 | 1985 | 300 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1986 | 148 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2006 | 224 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2005 | 321 | 0.020 |
Why?
|
| Synapsins | 1 | 2004 | 43 | 0.010 |
Why?
|
| Government | 1 | 1985 | 165 | 0.010 |
Why?
|
| Tryptophan | 2 | 1983 | 478 | 0.010 |
Why?
|
| Tryptamines | 1 | 1984 | 88 | 0.010 |
Why?
|
| Asparagine | 1 | 2004 | 122 | 0.010 |
Why?
|
| Demography | 1 | 2009 | 1656 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 1950 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3558 | 0.010 |
Why?
|
| Rosette Formation | 1 | 1982 | 153 | 0.010 |
Why?
|
| Genes, Recessive | 2 | 1997 | 641 | 0.010 |
Why?
|
| Autoimmune Diseases | 2 | 1986 | 2133 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1986 | 802 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 1987 | 528 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 2649 | 0.010 |
Why?
|
| Genes, Dominant | 2 | 1997 | 880 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 258 | 0.010 |
Why?
|
| Alcoholic Intoxication | 1 | 1984 | 188 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1986 | 981 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1986 | 1035 | 0.010 |
Why?
|
| Nervous System | 1 | 1986 | 554 | 0.010 |
Why?
|
| Radiography | 1 | 1993 | 7023 | 0.010 |
Why?
|
| Leucine | 1 | 2004 | 561 | 0.010 |
Why?
|
| Blinking | 1 | 1983 | 138 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1986 | 732 | 0.010 |
Why?
|
| CpG Islands | 1 | 2006 | 1172 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1984 | 1767 | 0.010 |
Why?
|
| Infant | 2 | 2010 | 35136 | 0.010 |
Why?
|
| Tyrosine | 2 | 1983 | 1461 | 0.010 |
Why?
|
| DNA Probes | 2 | 1994 | 560 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1981 | 40 | 0.010 |
Why?
|
| Fluphenazine | 1 | 1981 | 36 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1986 | 482 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1981 | 191 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2001 | 335 | 0.010 |
Why?
|
| Anthropometry | 1 | 1986 | 1350 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2019 | 0.010 |
Why?
|
| Proteins | 1 | 1996 | 6103 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 1682 | 0.010 |
Why?
|
| Ireland | 1 | 2000 | 161 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 671 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13408 | 0.010 |
Why?
|
| Amygdala | 1 | 1988 | 1315 | 0.010 |
Why?
|
| Serine | 1 | 2004 | 826 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2001 | 209 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 9959 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1984 | 2327 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1986 | 3870 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 1623 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1981 | 440 | 0.010 |
Why?
|
| Violence | 1 | 1985 | 909 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1982 | 1588 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 1985 | 1221 | 0.010 |
Why?
|
| Puerperal Disorders | 1 | 2001 | 275 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2726 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 16689 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 1701 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2001 | 959 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2011 | 23403 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2001 | 577 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1602 | 0.010 |
Why?
|
| TATA-Box Binding Protein | 1 | 1996 | 98 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 7722 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2010 | 6196 | 0.010 |
Why?
|
| Rats | 2 | 2010 | 24260 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3617 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2001 | 1117 | 0.010 |
Why?
|
| New Mexico | 1 | 1975 | 86 | 0.010 |
Why?
|
| Colorado | 1 | 1975 | 163 | 0.010 |
Why?
|
| England | 1 | 1996 | 522 | 0.010 |
Why?
|
| Cerebellar Ataxia | 1 | 1996 | 145 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13033 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1085 | 0.010 |
Why?
|
| Amino Acids | 1 | 1981 | 1736 | 0.010 |
Why?
|
| Informed Consent | 1 | 2001 | 995 | 0.010 |
Why?
|
| Africa | 1 | 1996 | 673 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1581 | 0.010 |
Why?
|
| Receptors, Dopamine D5 | 1 | 1994 | 32 | 0.010 |
Why?
|
| Glutamine | 1 | 1996 | 578 | 0.010 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 1996 | 259 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3798 | 0.010 |
Why?
|
| District of Columbia | 2 | 1985 | 157 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 2050 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2003 | 4026 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8436 | 0.010 |
Why?
|
| Piperidines | 1 | 1981 | 1602 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1993 | 458 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 1991 | 25043 | 0.010 |
Why?
|
| Sex | 1 | 1990 | 57 | 0.010 |
Why?
|
| India | 1 | 1996 | 2197 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1982 | 4665 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2001 | 8324 | 0.000 |
Why?
|
| Trisomy | 1 | 1989 | 266 | 0.000 |
Why?
|
| Psychomotor Performance | 2 | 1987 | 1901 | 0.000 |
Why?
|
| Fathers | 1 | 1990 | 358 | 0.000 |
Why?
|
| Caenorhabditis elegans | 1 | 1996 | 1419 | 0.000 |
Why?
|
| Coroners and Medical Examiners | 1 | 1986 | 10 | 0.000 |
Why?
|
| Recombination, Genetic | 1 | 1991 | 1586 | 0.000 |
Why?
|
| Electroshock | 1 | 1986 | 122 | 0.000 |
Why?
|
| Neuropeptide Y | 1 | 1987 | 200 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1982 | 9274 | 0.000 |
Why?
|
| North America | 1 | 1989 | 1249 | 0.000 |
Why?
|
| Putamen | 1 | 1986 | 291 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 2186 | 0.000 |
Why?
|
| Commitment of Mentally Ill | 1 | 1985 | 94 | 0.000 |
Why?
|
| Somatostatin | 1 | 1987 | 459 | 0.000 |
Why?
|
| Globus Pallidus | 1 | 1986 | 253 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1982 | 10180 | 0.000 |
Why?
|
| Chromatography, Gas | 1 | 1984 | 156 | 0.000 |
Why?
|
| Nitrogen Isotopes | 1 | 1984 | 84 | 0.000 |
Why?
|
| Biotransformation | 1 | 1984 | 168 | 0.000 |
Why?
|
| Peptides | 1 | 1996 | 4409 | 0.000 |
Why?
|
| Forearm | 1 | 1986 | 409 | 0.000 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1984 | 361 | 0.000 |
Why?
|
| Carbon Isotopes | 1 | 1984 | 467 | 0.000 |
Why?
|
| Marriage | 1 | 1985 | 339 | 0.000 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1983 | 147 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1983 | 419 | 0.000 |
Why?
|
| Auditory Perception | 1 | 1987 | 569 | 0.000 |
Why?
|
| Phenylketonurias | 1 | 1983 | 122 | 0.000 |
Why?
|
| Psychological Tests | 1 | 1984 | 651 | 0.000 |
Why?
|
| Discrimination Learning | 1 | 1984 | 280 | 0.000 |
Why?
|
| Evoked Potentials, Visual | 1 | 1984 | 427 | 0.000 |
Why?
|
| Emigration and Immigration | 1 | 1985 | 404 | 0.000 |
Why?
|
| Religion | 1 | 1985 | 356 | 0.000 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1984 | 525 | 0.000 |
Why?
|
| Microchemistry | 1 | 1981 | 57 | 0.000 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 1981 | 108 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1986 | 1063 | 0.000 |
Why?
|
| Thalamus | 1 | 1986 | 1023 | 0.000 |
Why?
|
| Synaptic Transmission | 1 | 1986 | 1178 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 1975 | 4371 | 0.000 |
Why?
|
| Autonomic Nervous System | 1 | 1984 | 671 | 0.000 |
Why?
|
| Thyrotropin | 1 | 1983 | 849 | 0.000 |
Why?
|
| Mothers | 1 | 1990 | 2165 | 0.000 |
Why?
|
| Politics | 1 | 1985 | 791 | 0.000 |
Why?
|
| Ethanol | 1 | 1984 | 1342 | 0.000 |
Why?
|
| Placebos | 1 | 1981 | 1676 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1983 | 1951 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1983 | 3913 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1983 | 1826 | 0.000 |
Why?
|
| Pain | 1 | 1984 | 4986 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1984 | 6150 | 0.000 |
Why?
|
| Models, Biological | 1 | 1985 | 9583 | 0.000 |
Why?
|